DXS International (AQSE:DXSP) FCF Margin %: 11.41% (As of Apr. 2025)


What is DXS International FCF Margin %?

DXS International AQSE:DXSP FCF Margin % is 11.41% as of Apr. 2025. The stock has 2 warning signs investors should review. Among 669 Healthcare Providers & Services companies, DXS International ranks better than 76.83% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. DXS International's Free Cash Flow for the six months ended in Apr. 2025 was £0.40 Mil. DXS International's Revenue for the six months ended in Apr. 2025 was £3.47 Mil. Therefore, DXS International's FCF Margin % for the quarter that ended in Apr. 2025 was 11.41%.

As of today, DXS International's current FCF Yield % is 49.50%.

The historical rank and industry rank for DXS International's FCF Margin % or its related term are showing as below:

AQSE:DXSP' s FCF Margin % Range Over the Past 10 Years
Min: -16.57   Med: -5.19   Max: 11.41
Current: 11.41

During the past 11 years, the highest FCF Margin % of DXS International was 11.41%. The lowest was -16.57%. And the median was -5.19%.

AQSE:DXSP's FCF Margin % is ranked better than
76.83% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 3.39 vs AQSE:DXSP: 11.41

DXS International FCF Margin % Related Terms

DXS International FCF Margin % Historical Data

* Premium members only.

The historical data trend for DXS International's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International FCF Margin % Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.07 -5.18 -16.57 -12.67 11.41

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -8.07 -5.18 -16.57 -12.67 11.41

AQSE:DXSP vs VEEV, BTSG, TEM: FCF Margin % Comparison

For the Health Information Services subindustry, DXS International's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DXS International FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DXS International's FCF Margin % distribution charts can be found below:

* The bar in red indicates where DXS International's FCF Margin % falls into.


DXS International FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

DXS International's FCF Margin for the fiscal year that ended in Apr. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Apr. 2025 )/Revenue (A: Apr. 2025 )
=0.396/3.47
=11.41 %

DXS International's FCF Margin for the quarter that ended in Apr. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Apr. 2025 )/Revenue (Q: Apr. 2025 )
=0.396/3.47
=11.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 11.41% mean?
DXS International (AQSE:DXSP) has a FCF Margin % of 11.41% as of Apr. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #155 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 23.2%.
Is DXS International's FCF Margin % too high?
DXS International's current FCF Margin % is 11.41%. The Healthcare Providers & Services industry median FCF Margin % is 3.39. DXS International's value of 11.41% is 236.6% above this industry median. Based on the distribution chart, DXS International ranks #155 out of 669 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does DXS International's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #155 out of 669 companies for FCF Margin %. This places DXS International in the top 23% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.39. DXS International's value of 11.41% is 236.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DXS International's current FCF Margin % of 11.41% is 236.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current FCF Margin % is 11.41%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current FCF Margin % is 11.41% and 236.6% above the Healthcare Providers & Services industry median of 3.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current FCF Margin % is 11.41% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DXS International Business Description

Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.